thiophenes has been researched along with Psoriasis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 5 (50.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Z; Ichii, O; Inaba, M; Kozai, M; Masum, MA; Mita, H; Takada, K; Wang, S | 1 |
| Gupta, R; Koo, JY; Levin, E; Liao, W; Wu, JJ | 1 |
| Fukuda, Y; Goto, M; Hayashi, Y; Inoue, H; Kadoshima-Yamaoka, K; Kanki, S; Murafuji, H; Murakawa, M; Nagahira, K; Nakatsuka, T; Ogata, A; Tanaka, Y; Yoshioka, R | 1 |
| Fleming, KF; Wu, JJ | 1 |
| Ebenezer, GJ; Hauer, P; McArthur, JC; Polydefkis, MJ; Tan, IL | 1 |
| Booth, K; Foerster, J; Hack, K; Kime, R; Norval, S; Palmer, C; Read, KD; Reilly, L | 1 |
| SAITO, T; SUGAI, T | 1 |
| Bramlett, KS; Burris, TP; Chandrasekhar, S; Chin, WW; Chintalacharuvu, SR; Iturria, SJ; Kato, S; Khalifa, B; Linebarger, JH; Lu, J; Ma, Y; Memezawa, A; Nagpal, S; Savkur, RS; Stayrook, KR; Yamamoto, Y; Yamaoka, K; Yee, YK; Yu, XP; Zeng, QQ | 1 |
| Iversen, L; Kragballe, K; Svendsen, M | 1 |
| Barr, RM; Black, AK; Dowd, PM; Greaves, MW; Isaacs, JL; Koro, O; Mistry, K | 1 |
10 other study(ies) available for thiophenes and Psoriasis
| Article | Year |
|---|---|
REV-ERB agonist suppresses IL-17 production in γδT cells and improves psoriatic dermatitis in a mouse model.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents; Cells, Cultured; Disease Models, Animal; Down-Regulation; Female; Interleukin-17; Intraepithelial Lymphocytes; Mice, Knockout; Nuclear Receptor Subfamily 1, Group D, Member 1; Psoriasis; Pyrrolidines; Signal Transduction; Skin; Thiophenes | 2021 |
Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient.
Topics: Adalimumab; Analgesics; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antidepressive Agents; Biological Products; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Pregabalin; Psoriasis; Thiophenes; Young Adult | 2013 |
Phosphodiesterase 7A inhibitor ASB16165 impairs proliferation of keratinocytes in vitro and in vivo.
Topics: Administration, Cutaneous; Animals; Bucladesine; Cell Proliferation; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 7; Disease Models, Animal; Epidermis; Female; Humans; Keratinocytes; Mice; Mice, Inbred BALB C; Phosphodiesterase Inhibitors; Psoriasis; Pyrazoles; Skin; Tetradecanoylphorbol Acetate; Thiophenes | 2010 |
Interaction between adalimumab with concurrent pregabalin and duloxetine administration in a psoriasis patient with diabetic peripheral neuropathy.
Topics: Adalimumab; Analgesics; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Drug Interactions; Duloxetine Hydrochloride; Female; gamma-Aminobutyric Acid; Humans; Pregabalin; Psoriasis; Selective Serotonin Reuptake Inhibitors; Thiophenes; Young Adult | 2011 |
Peripheral nerve toxic effects of nitrofurantoin.
Topics: Amines; Analgesics; Anti-Infective Agents, Urinary; Biopsy; Cyclohexanecarboxylic Acids; Cystitis, Interstitial; Duloxetine Hydrochloride; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Middle Aged; Nerve Fibers; Neurologic Examination; Nitrofurantoin; Paresthesia; Perineum; Peripheral Nervous System Diseases; Psoriasis; Skin; Thiophenes; Treatment Outcome; Urinary Tract Infections | 2012 |
Skin-targeted inhibition of PPAR β/δ by selective antagonists to treat PPAR β/δ-mediated psoriasis-like skin disease in vivo.
Topics: Administration, Topical; Animals; Benzamides; Disease Models, Animal; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Ointments; PPAR gamma; PPAR-beta; Psoriasis; Recombinant Proteins; Skin; Skin Absorption; Sulfones; Thiophenes | 2012 |
[TREATMENT OF SEVERAL SKIN DISEASES WITH REDUCDYN].
Topics: Adolescent; Biomedical Research; Child; Cysteine; Dermatitis; Drug Therapy; Eczema; Fructose; Humans; Pruritus; Psoriasis; Thiophenes | 1964 |
Identification and characterization of noncalcemic, tissue-selective, nonsecosteroidal vitamin D receptor modulators.
Topics: Acetates; Animals; Arylsulfonates; Caco-2 Cells; Calcitriol; Cell Proliferation; Cells, Cultured; Colonic Neoplasms; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Female; Humans; Hypercalcemia; Intestines; Keratinocytes; Ligands; Mice; Mice, Hairless; Mice, Inbred C57BL; Mice, Inbred Strains; Models, Biological; Osteoblasts; Psoriasis; Rats; Receptors, Calcitriol; Signal Transduction; Species Specificity; Thiophenes; Transcription, Genetic; Tumor Cells, Cultured; Vitamin D | 2006 |
Cyclosporin A down-regulates the LTA4 hydrolase level in human keratinocyte cultures.
Topics: 8,11,14-Eicosatrienoic Acid; Anti-Inflammatory Agents; Antineoplastic Agents; Calcitriol; Cells, Cultured; Cyclosporine; Dexamethasone; Down-Regulation; Epoxide Hydrolases; Humans; Interferon-gamma; Keratinocytes; Leukotriene B4; Methotrexate; Psoriasis; Thiophenes; Tretinoin | 1996 |
The in vitro 5-lipoxygenase and cyclo-oxygenase inhibitor L-652,343 does not inhibit 5-lipoxygenase in vivo in human skin.
Topics: Adult; Arachidonate Lipoxygenases; Cyclooxygenase Inhibitors; Dinoprostone; Humans; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; Male; Middle Aged; Prostaglandin D2; Prostaglandins D; Prostaglandins E; Psoriasis; Skin; Thiophenes | 1988 |